[
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 1,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 2,
        "comp_date_while_ongoing": 0,
        "has_results": 0,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "2008-03-10",
        "min_end_date": "2008-03-10",
        "name_of_sponsor": "Lilly S.A",
        "name_of_sponsor_orig": "Lilly S.A",
        "normalized_parent_name": "Lilly Megacorp",
        "normalized_name": "Lilly",
        "number_of_countries": 4,
        "overall_status": "completed-due",
        "parent_slug": "lilly-megacorp",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "lilly-sa",
        "results_expected": 1,
        "single_blind": 0,
        "slug": "lilly",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2004-000028-34",
        "trial_status": 1,
        "trial_title": "A randomised Phase 3 Trial of ALIMTA and Cisplatin versus GEMZAR and Cisplatin in Patients with locally advanced or metastatic Non-Small-Cell Lung Cancer",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000028-34"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 1,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 1,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 1,
        "comp_date_while_ongoing": 0,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 1,
        "max_end_date": "2005-06-30",
        "min_end_date": "2005-06-30",
        "name_of_sponsor": "Bristol Myers Squibb International Corporation",
        "name_of_sponsor_orig": "Bristol Myers Squibb International Corporation",
        "normalized_parent_name": "Bristol Myers Squib",
        "normalized_name": "Bristol Myers Squib",
        "number_of_countries": 1,
        "overall_status": "outside-eu",
        "parent_slug": "bristol-myers-squib",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "bristol-myers-squibb-international-corporation",
        "results_expected": 1,
        "single_blind": 0,
        "slug": "bristol-myers-squib",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2004-000033-11",
        "trial_status": 1,
        "trial_title": "The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Patients with Moderate Hypertension",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000033-11"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 3,
        "comp_date_while_ongoing": 1,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "2007-05-31",
        "min_end_date": "2007-05-31",
        "name_of_sponsor": "Glaxosmithkline, S.A.",
        "name_of_sponsor_orig": "GlaxoSmithkline, S.A.",
        "normalized_parent_name": "GlaxoSmithKline",
        "normalized_name": "GlaxoSmithKline",
        "number_of_countries": 7,
        "overall_status": "error-ongoing-has-comp-date",
        "parent_slug": "glaxosmithkline",
        "phase": 2,
        "rare_disease": 0,
        "raw_slug": "glaxosmithklinesro",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "glaxosmithkline",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2004-000406-51",
        "trial_status": 2,
        "trial_title": "A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of S...",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000406-51"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 3,
        "comp_date_while_ongoing": 1,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "2007-05-31",
        "min_end_date": "2007-05-31",
        "name_of_sponsor": "Sepsicure LLC",
        "name_of_sponsor_orig": "Sepsicure LLC",
        "normalized_parent_name": "Sepsicure LLC",
        "normalized_name": "Sepsicure LLC",
        "number_of_countries": 7,
        "overall_status": "error-ongoing-has-comp-date",
        "parent_slug": "sepsicure-llc",
        "phase": 2,
        "rare_disease": 0,
        "raw_slug": "sepsicure-llc",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "sepsicure-llc",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2004-000406-51",
        "trial_status": 2,
        "trial_title": "A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of S...",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000406-51"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 6,
        "comp_date_while_ongoing": 1,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "2007-11-22",
        "min_end_date": "2007-10-06",
        "name_of_sponsor": "AstraZeneca SAS",
        "name_of_sponsor_orig": "AstraZeneca SAS",
        "normalized_parent_name": "Astrazeneca",
        "normalized_name": "Astrazeneca",
        "number_of_countries": 7,
        "overall_status": "error-ongoing-has-comp-date",
        "parent_slug": "astrazeneca",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "astrazeneca-sas",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "astrazeneca",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2005-002892-34",
        "trial_status": 2,
        "trial_title": "Comparison of the Effects Noted in The ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acUte coronary Syndrome",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2005-002892-34"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "https://www1.actelion.com/media/media-releases?newsId=2113719",
        "any_terminated": 0,
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_terminated": 0,
        "all_completed_no_comp_date": 0,
        "bioequivalence_study": 0,
        "comp_date": 5,
        "comp_date_while_ongoing": 1,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "2008-05-06",
        "min_end_date": "2008-02-08",
        "name_of_sponsor": "Actelion pharmaceuticals Ltd",
        "name_of_sponsor_orig": "Actelion Pharmaceuticals Ltd",
        "normalized_parent_name": "Johnson & Johnson",
        "normalized_name": "Actelion Pharmaceuticals Ltd",
        "number_of_countries": 8,
        "overall_status": "error-ongoing-has-comp-date",
        "parent_slug": "johnson-johnson",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "actelion-pharmaceuticals-ltd",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "actelion-pharmaceuticals-ltd",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2006-002907-15",
        "trial_status": 2,
        "trial_title": "Multicenter, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of tezosentan in patients with pre-operative pulmonary hypertension, due...",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2006-002907-15"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "all_completed_no_comp_date": 0,
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 0,
        "comp_date_while_ongoing": 0,
        "has_results": 0,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "",
        "min_end_date": "",
        "name_of_sponsor": "Pirkanmaan sairaanhoitopiiri",
        "name_of_sponsor_orig": "Pirkanmaan sairaanhoitopiiri",
        "normalized_parent_name": "Pirkanmaa Hospital",
        "normalized_name": "Pirkanmaa Hospital",
        "number_of_countries": 4,
        "overall_status": "ongoing",
        "parent_slug": "pirkanmaa-hospital",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "pirkanmaan-sairaanhoitopiiri",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "pirkanmaa-hospital",
        "sponsor_status": 0,
        "total_trials": 1,
        "trial_id": "2007-004299-38",
        "trial_status": 0,
        "trial_title": "European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer.",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-004299-38"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 0,
        "comp_date_while_ongoing": 0,
        "has_results": 0,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "",
        "min_end_date": "",
        "name_of_sponsor": "The Royal Liverpool and Broadgreen University Hospital NHS Trust",
        "name_of_sponsor_orig": "The Royal Liverpool and Broadgreen University Hospital NHS Trust",
        "normalized_parent_name": "Royal Liverpool and Broadgreen University Hospitals NHS Trust",
        "normalized_name": "Royal Liverpool and Broadgreen University Hospitals NHS Trust",
        "number_of_countries": 4,
        "overall_status": "ongoing",
        "parent_slug": "royal-liverpool-and-broadgreen-university-hospitals-nhs-trust",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "the-royal-liverpool-and-broadgreen-university-hospital-nhs-trust",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "royal-liverpool-and-broadgreen-university-hospitals-nhs-trust",
        "sponsor_status": 0,
        "total_trials": 1,
        "trial_id": "2007-004299-38",
        "trial_status": 0,
        "trial_title": "European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer.",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-004299-38"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 0,
        "comp_date_while_ongoing": 0,
        "has_results": 0,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "",
        "min_end_date": "",
        "name_of_sponsor": "The University of Liverpool",
        "name_of_sponsor_orig": "The University of Liverpool",
        "normalized_parent_name": "University of Liverpool",
        "normalized_name": "University of Liverpool",
        "number_of_countries": 4,
        "overall_status": "ongoing",
        "parent_slug": "university-of-liverpool",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "the-university-of-liverpool",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "university-of-liverpool",
        "sponsor_status": 0,
        "total_trials": 1,
        "trial_id": "2007-004299-38",
        "trial_status": 0,
        "trial_title": "European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer.",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-004299-38"
    },
    {
        "Description": "",
        "Notes": "",
        "Proof": "",
        "only_non_eu": 0,
        "contains_non_eu": 0,
        "all_completed_no_comp_date": 0,
        "any_terminated": 0,
        "all_terminated": 0,
        "bioequivalence_study": 0,
        "comp_date": 0,
        "comp_date_while_ongoing": 0,
        "has_results": 1,
        "health_volunteers": 0,
        "includes_pip": 0,
        "exempt": 0,
        "max_end_date": "",
        "min_end_date": "",
        "name_of_sponsor": "Medicines Development (Infectious Diseases)",
        "name_of_sponsor_orig": "Medicines Development (Infectious Diseases)",
        "normalized_parent_name": "Unclear Sponsor Name Given",
        "normalized_name": "Unclear Sponsor Name Given - Medicines Development (Infectious Diseases)",
        "number_of_countries": 1,
        "overall_status": "no-trial-status",
        "parent_slug": "unclear-sponsor-name-given",
        "phase": 3,
        "rare_disease": 0,
        "raw_slug": "medicines-development-infectious-diseases",
        "results_expected": 0,
        "single_blind": 0,
        "slug": "unclear-sponsor-name-given-medicines-development-infectious-diseases",
        "sponsor_status": 1,
        "total_trials": 1,
        "trial_id": "2015-004907-22",
        "trial_status": 4,
        "trial_title": "A multicenter, open-label study to assess the efficacy and safety of potassium clavulanate/amoxicillin",
        "trial_url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-004907-22"
    }
]
